Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antitubercular chemotherapy]

S Jouveshomme1, B Dautzenberg

  • 1Service de Pneumologie et Réanimation Respiratoire, Groupe Hospitalier Pitié-Salpêtrière, Paris.

Revue Des Maladies Respiratoires
|March 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Deleterious effects of heated tobacco on respiratory symptoms and lung function].

Revue des maladies respiratoires·2024
Same author

Revue des maladies respiratoires actualites·2021
Same author

Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials.

Respiratory medicine and research·2021
Same author

Risk evaluation of the use of complementary and alternative medicines in cancer.

Annales pharmaceutiques francaises·2020
Same author

Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

[Systematic analysis of the scientific literature on heated tobacco].

Revue des maladies respiratoires·2018
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Effective tuberculosis treatment involves healing patients, preventing drug resistance, and controlling transmission. The standard 6-month regimen is effective, but adherence and multidrug resistance remain key challenges.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Tuberculosis (TB) treatment aims to cure patients, prevent drug resistance, and halt transmission.
  • Standard treatment regimens are crucial for managing both pulmonary and extra-pulmonary TB.
  • HIV-infected and uninfected individuals benefit from current TB therapeutic approaches.

Purpose:

  • To outline the goals and preferred treatment regimens for tuberculosis.
  • To identify factors contributing to treatment failure, including drug resistance and patient adherence.
  • To emphasize the importance of adequate treatment and compliance in preventing resistant TB strains.

Summary:

  • The preferred 6-month tuberculosis treatment includes isoniazid and rifampin, with pyrazinamide for the initial 2 months.

Related Experiment Videos

  • Ethambutol is added if isoniazid resistance is suspected, pending susceptibility results.
  • Treatment failure is primarily linked to poor patient adherence and the emergence of multidrug-resistant tuberculosis (MDR-TB).

    • Impact:

    • Highlights the effectiveness of standard TB regimens in diverse populations.
    • Underscores the critical need for patient adherence and robust treatment strategies to combat MDR-TB.
    • Informs public health strategies for TB control and prevention of antimicrobial resistance.